Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical immunotherapy approach using the neuroimmune system.
Key findingNeuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical imm
What the researchers found
Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical immunotherapy approach using the neuroimmune system.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Generating tolerogenic dendritic cells with neuropeptides.
Human immunology, 70(5), 300-7
Citation
Delgado, Mario. (2009). Generating tolerogenic dendritic cells with neuropeptides.. Human immunology, 70(5), 300-7.